INATHERYS is a clinical-stage biotech advancing precision drug delivery, turning cancer’s energy dependency against itself. Our lead asset, an ADC targeting CD71/TfR1, is designed to address critical needs in treating proliferative cancers.
Looking for a particular INATHERYS employee's phone or email?
The INATHERYS annual revenue was $4 million in 2026.
Emmanuel Gomez is the President - CEO of INATHERYS.
5 people are employed at INATHERYS.
INATHERYS is based in Evry Cedex, Wallis and Futuna.
The NAICS codes for INATHERYS are [54, 5417, 541, 54171, 541713].
The SIC codes for INATHERYS are [873, 87].